Tumour-infiltrating lymphocytes: from prognosis to treatment selection

K Brummel, AL Eerkens, M de Bruyn… - British Journal of …, 2023 - nature.com
Tumour-infiltrating lymphocytes (TILs) are considered crucial in anti-tumour immunity.
Accordingly, the presence of TILs contains prognostic and predictive value. In 2011, we …

Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment

J Taieb, M Svrcek, R Cohen, D Basile… - European Journal of …, 2022 - Elsevier
Microsatellite unstable (MSI) colorectal cancers (CRCs) are due to DNA mismatch repair
(MMR) deficiency and occurs in15% of non-metastatic diseases and 5% in the metastatic …

Predictive biomarkers of colon cancer immunotherapy: Present and future

W Hou, C Yi, H Zhu - Frontiers in immunology, 2022 - frontiersin.org
Immunotherapy has revolutionized colon cancer treatment. Immune checkpoint inhibitors
(ICIs) have shown clinical benefits for colon cancer patients, especially those with high …

Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial

ET Roussos Torres, WJ Ho, L Danilova, JA Tandurella… - Nature Cancer, 2024 - nature.com
We report the results of 24 women, 50%(N= 12) with hormone receptor-positive breast
cancer and 50%(N= 12) with advanced triple-negative breast cancer, treated with …

Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls

S Adeleke, A Haslam, A Choy, S Diaz-Cano… - Personalized …, 2022 - Taylor & Francis
We present the case of a patient with Lynch syndrome and metastatic colorectal carcinoma
(mCRC). The initial immunohistochemistry (IHC) test for deficient mismatch repair gave a …

Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma

Z Wang, X Wang, Y Xu, J Li, X Zhang, Z Peng, Y Hu… - BMC medicine, 2022 - Springer
Background A significant subset of mismatch repair-deficient (dMMR)/microsatellite
instability-high (MSI-H) gastric adenocarcinomas (GAC) are resistant to immune checkpoint …

[HTML][HTML] Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer

AGDA De Salins, G Tachon, R Cohen… - ESMO open, 2021 - Elsevier
Background DNA mismatch repair system deficiency (dMMR) is found in 15% of colorectal
cancers (CRCs). Two methods are used to determine dMMR, immunohistochemistry (IHC) of …

Tumor infiltrating lymphocytes (TILs) as a predictive biomarker of response to checkpoint blockers in solid tumors: a systematic review

D Presti, FG Dall'Olio, B Besse, JM Ribeiro… - Critical Reviews in …, 2022 - Elsevier
Immunotherapy is a standard of care in many solid tumors but many patients derive limited
benefit from it. There is increasing interest toward tumor infiltrating lymphocytes (TILs) since …

Resolving the paradox of colon cancer through the integration of genetics, immunology, and the microbiota

M Fidelle, S Yonekura, M Picard, A Cogdill… - Frontiers in …, 2020 - frontiersin.org
While colorectal cancers (CRC) are paradigmatic tumors invaded by effector memory
lymphocytes, the mechanisms accounting for the relative resistance of MSI negative CRC to …

[HTML][HTML] RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient …

R Cohen, J Bennouna, A Meurisse… - … for Immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) are highly effective in patients with
microsatellite instability/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer …